You are here

Abilify Maintena

FDA accepts Otsuka, Lundbeck filing for long-acting schizophrenia drug, teeing up April decision date

Fierce Pharma

Tue, 09/13/22 - 10:50 am

bipolar disorder

Abilify Maintena

Alkermes closer to launching once-monthly schizophrenia drug into a crowded market

Fierce Biotech

Tue, 08/26/14 - 10:36 pm

Abilify Maintena

Lundbeck, Otsuka get positive opinion for schizophrenia drug

Reuters

Fri, 09/20/13 - 09:42 am

Abilify Maintena

Otsuka, Lundbeck Win Approval for Monthly Abilify Shot

Bloomberg

Fri, 03/1/13 - 11:12 am

Abilify Maintena